Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival

Breast Cancer Research and Treatment

Volumn 120, Issue 3, 2010, Pages 745-752

  Cleveland, Rebecca J ^f   Gammon, Marilie D ^a   Long, Chang Min ^b   Gaudet, Mia M ^c   Eng, Sybil M ^d   Teitelbaum, Susan L ^e   Neugut, Alfred I ^b   Santella, Regina M ^b  

^a IL   (United States)

^b Columbia University ^*  (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d PFIZER INC   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

Breast cancer; Leptin; Leptin receptor; Obesity; Polymorphism

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MODIFICATION; DNA POLYMORPHISM; EUROPEAN AMERICAN; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CAUSE OF DEATH; EUROPE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; LEPTIN; MENOPAUSE; NEW YORK; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, LEPTIN; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77950857617     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0503-1     Document Type: Article

References (45)

1. World Health Organization (WHO) (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894 (i-xii): 1-253
2. Stephenson GD, Rose DP (2003) Breast cancer and obesity: an update. Nutr Cancer 45:1-16
3. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686-1691 (Pubitemid 40995080)
4. LamarCA,DorganJF,LongcopeC,StanczykFZ,FalkRT,StephensonHEJr(2003) Serumsexhormonesandbreastcancerriskfactorsinpostmenopausalwomen. CancerEpidemiolBiomarkersPrev12:380-383(Pubitemid36428000)
5. SchwartzMW,BaskinDG,KaiyalaKJ,WoodsSC(1999) Modelfortheregulationofenergybalanceandadipositybythecentralnervoussystem. AmJClinNutr69:584-596(Pubitemid29193380)
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432 (Pubitemid 24365442)
7. Hamilton BS, Paglia D, Kwan AY, Deitel M (1995) Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1:953-956
8. Baratta M (2002) Leptin- from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit 8: RA282-RA292
9. Rose DP, Gilhooly EM, Nixon DW (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 21:1285-1292
10. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR (2006) Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281:26320-26328 (Pubitemid 44401840)
11. Dieudonne MN, Sammari A, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006) Sex steroids and leptin regulate 11beta-hydroxySteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities. J Steroid Biochem Mol Biol 99:189-196 (Pubitemid 43786264)
12. Huang L, Li C (2000) Leptin: a multifunctional hormone. Cell Res 10:81-92
13. Falk RT, Brinton LA, Madigan MP, Potischman N, Sturgeon SR, Malone KE, Daling JR (2006) Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women, Breast Cancer Res Treat 98:157-165
14. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D (2000) Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11:383-388 (Pubitemid 30345235)
15. Stattin P, Soderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, Olsson T (2004) Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 86:191-196 (Pubitemid 39070961)
16. Coleman DL (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148
17. Friedman JM, Leibel RL, Siegel DS, Walsh J, Bahary N (1991) Molecular mapping of the mouse ob mutation. Genomics 11:1054-1062
18. Chagnon YC, Wilmore JH, Borecki IB, Gagnon J, Perusse L, Chagnon M, Collier GR, Leon AS, Skinner JS, Rao DC, Bouchard C (2000) Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab 85:29-34 (Pubitemid 32268785)
19. Mammes O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F (2000) Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 64:391-394 (Pubitemid 32055730)
20. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, KlimisZacas D, Mantzoros CS (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 86:4434-4439 (Pubitemid 32848571)
21. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Amer P (2002) A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 34:355-359
22. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Wolff MS, Stellman SD, Kabat GC, Levin B, Bradlow HL, Hatch M, Beyea J, Camann D, Trent M, Senie RT, Garbowski GC, Maffeo C, Montalvan P, Berkowitz GS, Kemeny M, Citron M, Schnabe F, Schuss A, Hajdu S, Vincguerra V, Coliman GW, Obrams GI (2002) The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74:235-254 (Pubitemid 34848352)
23. Waksberg J (1978) Sampling methods for random digit dialing. J Am Stat Assoc 73:40-46
24. Ribeiro R, Araujo AP, Coelho A, Catarino R, Pinto D, Araujo A, Calcada C, Lopes C, Medeiros R (2006) A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 42:1188-1193
25. Ross JA, Oeffinger KC, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y, Robison LL (2004) Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 22:3558-3562 (Pubitemid 41103662)
26. Willett EV, Skibola CF, Adamson P, Skibola DR, Morgan GJ, Smith MT, Roman E (2005) Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 93:811-816 (Pubitemid 41486443)
27. Hosmer D, Lemeshow S (1989) Applied logistic regression. John Wiley, New York.
28. Allison P (1995) Survival analysis using SAS: a practical guide. SAS, Cary
29. World Health Organization (WHO) (1995) Report of a WHO expert committee. Physical status: the use and interpretation of anthropometry. WHO, Geneva
30. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N (2005) Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23:6037-6042
31. Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10:4325-4331 (Pubitemid 38878870)
32. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, Noguchi S (2006) High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118:1414-1419 (Pubitemid 43306527)
33. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L (2006) Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6:38 (Pubitemid 43380715)
34. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lobo F, Lopes C, Medeiros R (2004) Overexpressing leptin genetic polymorphism. (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 59:268-274
35. SkibolaCF,HollyEA,ForrestMS,HubbardA,BracciPM,SkibolaDR,HegedusC, SmithMT(2004)Bodymassindex,leptinandleptinreceptorpolymorphisms, andnon-hodgkinlymphoma.CancerEpidemiolBiomarkersPrev13:779- 786(Pubitemid38737867)
36. HuX,JunejaSC,MaihleNJ,ClearyMP(2002)Leptin- agrowthfactorinnormalandmalignantbreastcellsandfornormalmammaryglanddevelopment. JNatlCancerInst94:1704-1711(Pubitemid35446839)
37. Mantzoros CS, Bolhke K, Moschos S, Cramer DW (1999) Leptin in relation to carcinoma in situ of the breast: a study of premenopausal cases and controls. Int J Cancer 80:523-526 (Pubitemid 29047515)
38. Woo HY, Park H, Ki CS, Park YL, Bae WG (2006) Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 237:137-142
39. Ogawa T, Hirose H, Yamamoto Y, Nishikai K, Miyashita K, Nakamura H, Saito I, Saruta T (2004) Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism 53:879-885 (Pubitemid 38829462)
40. Roth MJ, Paltoo DN, Albert PS, Baer DJ, Judd JT, Tangrea J, Taylor PR (2005) Common leptin receptor polymorphisms do not modify the effect of alcohol ingestion on serum leptin levels in a controlled feeding and alcohol ingestion study. Cancer Epidemiol Biomarkers Prev 14:1576-1.578 (Pubitemid 40807367)
41. Paracchini V, Pedotti P, Taioli E (2005) Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 162:101-114 (Pubitemid 41373535)
42. Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128-1143 (Pubitemid 34141858)
43. Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD (2007) Weight gain prior to breast cancer diagnosis and survival. Cancer Epidemiol Biomarkers Prev (in press)
44. Eng SM, Gammon MD, Terry MB, Kushi LH, Teitelbaum SL, Britton JA, Neugut AI (2005) Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol 162:229-237
45. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J (2003) Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) 58:213-219 (Pubitemid 36194277)